Top 20 in US Stock Trading Volume: Microsoft's stock price soared by more than 7%
On Thursday, Tesla closed down 0.58%, with a trading volume of $28.048 billion. On April 30th, a well-known US financial media reported that Tesla's board of directors was looking for a new Chief Executive Officer (CEO) to replace Elon Musk. However, this statement was denied by Robyn Denholm, the chairperson of Tesla in the United States.
Denholm posted on the social platform X on May 1st, stating that Tesla's directors "have great confidence" in Musk's abilities.
Denholm wrote, "A certain media wrongly reported that Tesla's board of directors contacted a recruitment agency and started searching for a CEO... This is absolutely incorrect... The CEO of Tesla is Elon Musk. The board of directors firmly believes that Musk has the ability to continue implementing the exciting growth plan."
NVIDIA, ranking second in trading volume, closed up 2.47%, with a trading volume of $26.4 billion. After technology giants Meta and Microsoft reaffirmed their aggressive artificial intelligence investment plans, chip stocks such as NVIDIA generally rose.
According to informed sources on Thursday, the United States is considering relaxing the control over NVIDIA's chip exports to the United Arab Emirates. Donald Trump may announce the launch of a bilateral chip trade during his upcoming trip to the Gulf region.
The source said that there has been no formal decision yet, and emphasized that the debate on semiconductor trade rules for the UAE and other countries is still ongoing in Washington. However, the discussion about amending the control of artificial intelligence chips for the UAE has received increasing support from both the US Department of Commerce and the White House.
Microsoft, ranking third in trading volume, closed up 7.63%, with a trading volume of $25.358 billion. Microsoft's revenue in the third fiscal quarter was $70.066 billion, an increase of 13% compared to the same period last year's $61.858 billion.
Excluding the impact of exchange rate changes, it increased by 15% year-on-year; the net profit was $25.824 billion, an increase of 18% compared to the same period last year's $21.939 billion. Excluding the impact of exchange rate changes, it increased by 19% year-on-year.
Microsoft's revenue and earnings per share in the third fiscal quarter both exceeded the previous expectations of Wall Street analysts, thus driving its stock price to rise significantly.
Meta Platforms, ranking fourth in trading volume, closed up 4.23%, with a trading volume of $17.907 billion. Meta announced its first-quarter financial report, with revenue of $42.31 billion and profit of $17.56 billion in that quarter, a year-on-year increase of 27%.
Advertising revenue in the first quarter was $41.39 billion, a year-on-year increase of 16%. The revenue of Reality Labs in the first quarter was $412 million, with an operating loss of $4.21 billion. The revenue of APP Family in the first quarter was $41.9 billion, with an operating profit of $21.77 billion.
The financial report shows that as of March 2025, Meta's average daily active user number was 3.43 billion, a year-on-year increase of 6%.
Meta's applications cover multiple fields such as social networking, communication, and virtual reality, including Facebook, Instagram, WhatsApp, etc.
Facebook, since its establishment in 2004, has attracted users worldwide with its powerful social network and rich functions, becoming an irreplaceable social tool and still firmly occupying the top position among global social platforms.
Amazon, ranking fifth in trading volume, closed up 3.13%, with a trading volume of $12.359 billion. Amazon's revenue in the first quarter was $155.7 billion, compared with a market expectation of $154.92 billion and $143.31 billion in the same period last year; the operating profit in the first quarter was $18.4 billion, compared with an estimate of $17.51 billion; the net sales of AWS in the first quarter was $29.3 billion, compared with a market expectation of $29.41 billion.
It is expected that the net sales in the second quarter will be between $159 billion and $164 billion; the company expects the operating profit in the second quarter to be between $13 billion and $17.5 billion, while analysts expect it to be $17.82 billion.
Eli Lilly, ranking eighth in trading volume, closed down 11.66%, suffering the worst single-day performance since 2008, with a trading volume of $10.252 billion. Eli Lilly's revenue in the first quarter was $12.73 billion, compared with an estimate of $12.67 billion. The company expects full-year revenue to be between $58 billion and $61 billion, while the market expects it to be $59.66 billion; it expects adjusted earnings per share for the full year to be between $20.78 and $22.2, compared with a previous expectation of $22.5 to $24.
Senior executives of the company said that the already announced and currently effective tariffs will not have a substantial impact on the company's financial outlook for 2025.
Robinhood Markets, ranking twelfth in trading volume, closed down 5.07%, with a trading volume of $4.201 billion. The company's revenue in the first quarter increased by 50% year-on-year to $927 million, slightly higher than the market expectation; earnings per share were 37 cents, also higher than the expected 33 cents.
The trading-based revenue of the cryptocurrency business increased by 100% to $252 million, while the trading-based revenue of options increased by 55%, and that of stocks increased by 44%. Robinhood said that the number of customers in the first quarter reached 25.8 million, including 3.2 million Robinhood Gold subscribers.
Taiwan Semiconductor Manufacturing Company (TSMC), ranking fourteenth in trading volume, closed up 3.62%, with a trading volume of $3.814 billion. According to media reports, while the Trump administration in the United States plans to increase semiconductor tariffs, TSMC has started the engineering construction of its third wafer fab (the 2nm wafer fab) in Arizona, the United States, to accelerate its expansion in the US.
TSMC previously announced an investment of $65 billion to build three wafer fabs, including: the first-phase 4nm wafer fab, which started mass production at the end of last year; the second-phase 3nm wafer fab, which was originally scheduled to start mass production in 2026 but was later postponed to 2028; the third-phase wafer fab will produce 2nm or more advanced A16 process technology, originally planned for mass production between 2029 and 2030.
However, previous rumors indicated that in response to the requests of major customers such as AMD and Apple, TSMC's original plan for the P2A equipment installation of the second factory in Arizona in the fourth quarter of 2026 has informed suppliers to move in and install the equipment in September this year, and the mass production time is also expected to be advanced by at least two quarters.
Qualcomm, ranking seventeenth in trading volume, closed down 8.92%, with a trading volume of $3.104 billion.
Qualcomm's revenue in the second fiscal quarter was $10.979 billion, an increase of 17% compared with $9.389 billion in the same period last year; the net profit was $2.812 billion, an increase of 21% compared with $2.326 billion in the same period last year; according to non-GAAP, Qualcomm's adjusted net profit in the second fiscal quarter was $3.172 billion, an increase of 15% compared with $2.761 billion in the same period last year.
Qualcomm's revenue and adjusted earnings per share in the second fiscal quarter both exceeded the expectations of Wall Street analysts. However, at the same time, the company's outlook for revenue and adjusted earnings per share in the third fiscal quarter did not meet expectations.
Becton, Dickinson and Company (BD), ranking twentieth in trading volume, closed down 18.13%, suffering the worst single-day decline in 26 years, with a trading volume of $2.325 billion and a market value evaporation of approximately $12 billion.
The medical product manufacturer said that the reduction of global government research funding, especially the reduction of scientific research appropriations announced by the United States in February, has led to a significant decline in the sales of its scientific research instruments.
The company warned that pressure has already been felt in the second fiscal quarter, and it will continue to face pressure throughout the 2025 fiscal year. It is expected that Trump's tariff policy will reduce its earnings per share by $0.25 in 2025. The adjusted full-year EPS expectation has been lowered to $14.06 - $14.34, lower than the market expectation of $14.43.
The company's diagnostic business also encountered obstacles simultaneously. The diagnostic department faced "headwinds" in the second fiscal quarter, but it did not specifically state whether it was related to the increase in supply chain costs caused by tariffs.
Morgan Stanley urgently lowered the target price of BD from $280 to $235, and pointed out: "The downward cycle of scientific research funding combined with tariff costs will lead the medical device industry to enter a 2-3 year adjustment period."
BD's CEO, Tom Polen, said that production will be accelerated to be transferred to Mexico and Eastern Europe, but he admitted that "it will take at least 18 months to complete the capacity restructuring."
Analysts estimate that the transfer cost may further erode the EPS by approximately $0.15 in 2025.